Discontinuation of tenofovir disoproxil fumarate from initial ART regimens because of renal adverse events: An analysis of data from four multi-country clinical trials

Bibliographic Details
Main Authors: McNeil Ngongondo, Justin Ritz, Michael D. Hughes, Mitch Matoga, Mina C. Hosseinipour
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Series:PLOS Global Public Health
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10766173/?tool=EBI
_version_ 1797362325566521344
author McNeil Ngongondo
Justin Ritz
Michael D. Hughes
Mitch Matoga
Mina C. Hosseinipour
author_facet McNeil Ngongondo
Justin Ritz
Michael D. Hughes
Mitch Matoga
Mina C. Hosseinipour
author_sort McNeil Ngongondo
collection DOAJ
first_indexed 2024-03-08T16:05:29Z
format Article
id doaj.art-637f50579432418dbb97f893bfcb4266
institution Directory Open Access Journal
issn 2767-3375
language English
last_indexed 2024-03-08T16:05:29Z
publishDate 2024-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLOS Global Public Health
spelling doaj.art-637f50579432418dbb97f893bfcb42662024-01-08T05:55:51ZengPublic Library of Science (PLoS)PLOS Global Public Health2767-33752024-01-0141Discontinuation of tenofovir disoproxil fumarate from initial ART regimens because of renal adverse events: An analysis of data from four multi-country clinical trialsMcNeil NgongondoJustin RitzMichael D. HughesMitch MatogaMina C. Hosseinipourhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10766173/?tool=EBI
spellingShingle McNeil Ngongondo
Justin Ritz
Michael D. Hughes
Mitch Matoga
Mina C. Hosseinipour
Discontinuation of tenofovir disoproxil fumarate from initial ART regimens because of renal adverse events: An analysis of data from four multi-country clinical trials
PLOS Global Public Health
title Discontinuation of tenofovir disoproxil fumarate from initial ART regimens because of renal adverse events: An analysis of data from four multi-country clinical trials
title_full Discontinuation of tenofovir disoproxil fumarate from initial ART regimens because of renal adverse events: An analysis of data from four multi-country clinical trials
title_fullStr Discontinuation of tenofovir disoproxil fumarate from initial ART regimens because of renal adverse events: An analysis of data from four multi-country clinical trials
title_full_unstemmed Discontinuation of tenofovir disoproxil fumarate from initial ART regimens because of renal adverse events: An analysis of data from four multi-country clinical trials
title_short Discontinuation of tenofovir disoproxil fumarate from initial ART regimens because of renal adverse events: An analysis of data from four multi-country clinical trials
title_sort discontinuation of tenofovir disoproxil fumarate from initial art regimens because of renal adverse events an analysis of data from four multi country clinical trials
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10766173/?tool=EBI
work_keys_str_mv AT mcneilngongondo discontinuationoftenofovirdisoproxilfumaratefrominitialartregimensbecauseofrenaladverseeventsananalysisofdatafromfourmulticountryclinicaltrials
AT justinritz discontinuationoftenofovirdisoproxilfumaratefrominitialartregimensbecauseofrenaladverseeventsananalysisofdatafromfourmulticountryclinicaltrials
AT michaeldhughes discontinuationoftenofovirdisoproxilfumaratefrominitialartregimensbecauseofrenaladverseeventsananalysisofdatafromfourmulticountryclinicaltrials
AT mitchmatoga discontinuationoftenofovirdisoproxilfumaratefrominitialartregimensbecauseofrenaladverseeventsananalysisofdatafromfourmulticountryclinicaltrials
AT minachosseinipour discontinuationoftenofovirdisoproxilfumaratefrominitialartregimensbecauseofrenaladverseeventsananalysisofdatafromfourmulticountryclinicaltrials